Europe Transfection Reagents and Equipment Market Forecast to 2030

Europe Transfection Reagents and Equipment Market Forecast to 2030

Europe Transfection Reagents and Equipment Market Forecast to 2030 – Regional Analysis – by Product (Reagents and Instruments), Method (Viral Methods, Non Viral Methods, and Hybrid Methods), Application (Biomedical Research, Protein Production, and Therapeutic Delivery), and End User (Academics & Research Institutes and Pharmaceutical & Biotechnology Companies)

Send Enquiry
Item ID: BMIRE00030436 Category: Tag:

$2,485 – $3,885

Description

The Europe transfection reagents and equipment market was valued at US$ 306.04 million in 2022 and is expected to reach US$ 555.46 million by 2030; it is estimated to register at a CAGR of 7.7% from 2022 to 2030.

Strategic Initiatives by Companies Drive Europe Transfection Reagents and Equipment Market

Transfection is the complex step in the overall process of developing a viral vector, which includes adenovirus, adeno-associated virus, and lentivirus. As the manufacturing processes are scaled up, transient transfection must also be ramped up. Process equipment vendors, drug developers, and raw material suppliers are focusing on collaborations to develop cost-effective, practical, and platformizable solutions for the rapid development and scaling up of viral vector manufacturing processes. On small scales, with planned material volumes and transfer & mixing times, transfecting cells with multiple plasmids becomes feasible. Scaling up requires experience in industrializing the transfection step since most companies only have transfection experience at the lab level. However, the volume of cell-culture media and transfection reagents required for scaling up the process to a larger level can be impractical, which emphasizes the need for optimization. Nonetheless, broadening the scale of production has become common in recent years with the surging demand for viral vectors. With numerous challenges associated with large-scale transfection processes, the best approach to increase production is by reducing the process rather than scaling up the process. This top-down approach allows clear identification of the conditions that will impact the process at the industrial level such as the volume of transfection complex solution. This approach also facilitates process optimization and decision-making. The development of such approaches to ramp up the small-scale transfection processes acts as an opportunity for the growth of the Europe transfection reagents and equipment market.

Europe Transfection Reagents and Equipment Market Overview

Europe region segmented into UK, Germany, France, Spain, Italy, and Rest of Europe. United Kingdom holds the largest market share in the year 2022. The growth of the pharmaceutical industry is determined by the high-quality research and development ongoing in the country, and extensive and flourishing healthcare knowledge base. The UK is one of the world’s best ecosystems for research, development, manufacturing, clinical adoption, and reimbursement of advanced therapeutics. Currently, over 85 clinical trials are ongoing in the UK, and 70 CGT companies are striving to develop potentially curative therapies. Catapult is a top company that has been contributing significantly to the CGT ecosystem in the UK; it stands as one of the top five companies involved in developing manufacturing processes of reagents and devices in the country. The company is focused on developing smarter automated CGT manufacturing processes that can automatically adapt to changing environments and process requirements with minimal intervention. Therefore, efforts made by UK-based companies to enhance productivity and reduce final product costs are the major factors driving the growth of the cell and gene therapy market in the UK. Moreover, the UK holds a strong position in the cell and gene therapy market in Europe owing to sustained and targeted investment in research, which further benefits the market.

Moreover, France has the presence of biopharmaceutical and pharmaceutical giants such as Sanofi S.A., Ipsen, Pierre Fabre, HRA Pharma, and TxCell (Sangamo Therapeutics, Inc.). These companies are involved in the development of vaccines and antibodies, among others, which require freeze-drying for their products, which contributes to the demand for transfection reagents and equipment.

Europe Transfection Reagents and Equipment Market Revenue and Forecast to 2030 (US$ Million)

Europe Transfection Reagents and Equipment Market Segmentation

The Europe transfection reagents and equipment market is segmented based on product, method, application, end user, and country.

Based on product, the Europe transfection reagents and equipment market is bifurcated into reagents and instruments. The reagents segment held a larger share in 2022.

In terms of method, the Europe transfection reagents and equipment market is segmented into viral methods, non-viral methods, and hybrid methods. The non-viral methods segment held the largest share in 2022. The viral segment is subcategorized into retrovirus, adenovirus, adeno associated virus, and herpes virus. The non-viral segment is bifurcated into physical/mechanical method and chemical method. Further, the physical/mechanical method segment is subcategorized into electroporation, microinjection, biolistic method, laser method, magnetofection, and sonoporation. Also, the chemical method segment is subcategorized into liposomal based/high lipid and non-liposomal/high lipid based.

By application, the Europe transfection reagents and equipment market is segmented into biomedical research, protein production, and therapeutic delivery. The biomedical research segment held the largest share in 2022.

Based on end user, the Europe transfection reagents and equipment market is bifurcated into academics & research institutes and pharmaceutical & biotechnology companies. The academics & research institutes segment held a larger share in 2022.

Based on country, the Europe transfection reagents and equipment market is categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The UK dominated the Europe transfection reagents and equipment market in 2022.

Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, MaxCyte Inc, and Polyplus-Transfection SA are some of the leading companies operating in the Europe transfection reagents and equipment market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

At 7.7% CAGR, Europe Transfection Reagents and Equipment Market is Speculated to be Worth US$ 555.46 Million by 2030, says the Research Team

According to the Research Team’ research, the Europe transfection reagents and equipment market was valued at US$ 306.04 million in 2022 and is expected to reach US$ 555.46 million by 2030, registering a CAGR of 7.7% from 2022 to 2030. Growing economic burden of cancer and ramping up small-scale processes to large-scale processes are among the critical factors attributed to the Europe transfection reagents and equipment market expansion.

According to the World Health Organization (WHO), cancer is one of the leading causes of death worldwide, and it accounted for ~10 million deaths in 2020. As per the International Agency for Research on Cancer, the global cancer burden is likely to increase with the addition of 30.2 million more cases by 2040. According to the Breast Cancer Organization, approximately 5-10% of breast cancer cases worldwide are hereditary and are caused by abnormal genes passed from generations. According to the article “Lifestyle, Genetic Risk and Incidence of Cancer,” published in the International Journal of Epidemiology in 2023, nearly 33% of cancer conditions that occur are hereditary, and the risk of genetic mutations is high in the disease. Hence, people are opting for genetic profiling for the early detection and personalized treatment of hereditary cancer cases. BRCA1 and BRCA2 are sometimes referred to as tumor suppressor genes. People who inherit the harmful variants of one of these genes are at a greater risk of several cancers, most notably breast and ovarian cancer, among other types. These people also tend to develop cancer at younger ages compared to people who do not have variations in the said genes. Studies focused on nucleic acid processing by cancer cells are likely to help understand cancer metabolism. DNA is typically packaged into a viral or non-viral particle to be transferred into the cell that is to be transfected. Gene transfer has been proposed as a new approach to enhance the effectiveness of antitumor drugs in treating intractable or metastatic cancers. The association of gene therapy and drugs (similar therapy) has been reported to strengthen the antiproliferative effects of classical treatments in lung, colorectal, pancreatic, bladder, and breast cancers, among others. Thus, the elevating economic burden of cancer bolsters the Europe transfection reagents and equipment market.

On the contrary, high cost of instruments and consumables hampers the growth of Europe transfection reagents and equipment market.

Based on product, the Europe transfection reagents and equipment market is bifurcated into reagents and instruments. The reagents segment held 74.9% share of the Europe transfection reagents and equipment market in 2022, amassing US$ 229.09 million. It is projected to garner US$ 419.64 million by 2030 to expand at 7.9% CAGR during 2022-2030.

In terms of method, the Europe transfection reagents and equipment market is segmented into viral methods, non viral methods, and hybrid methods. The non-viral methods segment held 57.5% share of the Europe transfection reagents and equipment market in 2022, amassing US$ 176.00 million. It is estimated to garner US$ 323.30 million by 2030 to expand at 7.9% CAGR during 2022-2030. The viral segment is sub categorized into retrovirus, adenovirus, adeno associated virus, and herpes virus. The non-viral segment is bifurcated into physical/mechanical method and chemical method. Further, the physical/mechanical method segment is sub categorized into electroporation, microinjection, biolistic method, laser method, magnetofection, and sonoporation. Also, the chemical method segment is subcategorized into liposomal based/high lipid and non-liposomal/high lipid based.

By application, the Europe transfection reagents and equipment market is segmented into biomedical research, protein production, and therapeutic delivery. The biomedical research segment held 52.9% share of Europe transfection reagents and equipment market in 2022, amassing US$ 161.85 million. It is predicted to garner US$ 297.85 million by 2030 to expand at 7.9% CAGR during 2022-2030.

Based on end user, the Europe transfection reagents and equipment market is bifurcated into academics & research institutes and pharmaceutical & biotechnology companies. The academics & research institutes segment held 65.9% share of the Europe transfection reagents and equipment market in 2022, amassing US$ 201.56 million. It is projected to garner US$ 363.55 million by 2030 to expand at 7.7% CAGR during 2022-2030.

Based on country, the Europe transfection reagents and equipment market is categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The UK held 28.3% share of Europe transfection reagents and equipment market in 2022, amassing US$ 86.46 million. It is projected to garner US$ 160.34 million by 2030 to expand at 8.0% CAGR during 2022-2030.

Key players operating in the Europe transfection reagents and equipment market are Thermo Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, MaxCyte Inc, and Polyplus-Transfection SA, among others.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe transfection reagents and equipment market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Europe transfection reagents and equipment market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS

1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Transfection Reagents and Equipment Market – Key Market Dynamics
4.1 Europe Transfection Reagents and Equipment Market – Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Popularity of Cell and Gene Therapy
4.2.2 Growing Economic Burden of Cancer
4.3 Market Restraints
4.3.1 High Cost of Instruments and Consumables
4.4 Market Opportunities
4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
4.5 Future Trends
4.5.1 Strategic Initiatives by Companies
4.6 Impact of Drivers and Restraints:
5. Transfection Reagents and Equipment Market – Europe Market Analysis
5.1 Europe Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
5.2 Europe Transfection Reagents and Equipment Market Forecast Analysis
6. Europe Transfection Reagents and Equipment Market Analysis – by Product
6.1 Reagents
6.1.1 Overview
6.1.2 Reagents: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
6.2 Equipment
6.2.1 Overview
6.2.2 Equipment: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7. Europe Transfection Reagents and Equipment Market Analysis – by Modality
7.1 Viral
7.1.1 Overview
7.1.2 Viral: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.1.2.1 Retrovirus: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.1.2.2 Adenovirus: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.1.2.3 Adeno-Associated Virus: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.1.2.4 Herpes Virus: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.2 Non-Viral
7.2.1 Overview
7.2.2 Non-Viral: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2.1 Physical/Mechanical Method: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.1 Electroporation: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.2 Microinjection: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.3 Biolistic Method: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.4 Laser Method: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.5 Magnetofection: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.6 Sonoporation: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2.2 Chemical Method: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.1 Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.2 Non-Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Hybrid
7.3.1 Overview
7.3.2 Hybrid: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe Transfection Reagents and Equipment Market Analysis – by Application
8.1 Biomedical Research
8.1.1 Overview
8.1.2 Biomedical Research: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Protein Production
8.2.1 Overview
8.2.2 Protein Production: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Therapeutic Delivery
8.3.1 Overview
8.3.2 Therapeutic Delivery: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe Transfection Reagents and Equipment Market Analysis – by End Users
9.1 Academic and Research Institutes
9.1.1 Overview
9.1.2 Academic and Research Institutes: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Pharmaceutical and Biotechnological Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnological Companies: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe Transfection Reagents and Equipment Market -Country Analysis
10.1 Europe: Transfection Reagents and Equipment Market – Revenue and Forecast Analysis – by Country
10.1.1 Europe: Transfection Reagents and Equipment Market – Revenue and Forecast Analysis – by Country
10.1.2 United Kingdom: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.2.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.2.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.2.2.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.2.2.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.2.3 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.2.4 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.3 Germany: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.3.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.3.2.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.3.2.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.3.2.2.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.3.2.2.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.3.3 Germany: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.3.4 Germany: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.4 France: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
10.1.4.1 France: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.4.2 France: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.4.2.1 France: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.4.2.2 France: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.4.2.2.1 France: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.4.2.2.2 France: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.4.3 France: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.4.4 France: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.5 Italy: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.5.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.5.2.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.5.2.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.5.2.2.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.5.2.2.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.5.3 Italy: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.5.4 Italy: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.6 Spain: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
10.1.6.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.6.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.6.2.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.6.2.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.6.2.2.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.6.2.2.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.6.3 Spain: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.6.4 Spain: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.7 Rest of Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
10.1.7.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.7.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.7.2.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.7.2.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.7.2.2.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.7.2.2.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.7.3 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.7.4 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by End Users
11. Transfection Reagents and Equipment Market -Industry Landscape
11.1 Overview
11.2 Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Promega Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bio-Rad Laboratories Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Mirus Bio LLC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 QIAGEN NV
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck KGaA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Lonza Group AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 MaxCyte Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Polyplus-Transfection SA
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us

LIST OF TABLES

Table 1. Europe Transfection Reagents and Equipment Market Segmentation
Table 2. Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Table 3. Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million) – by Product
Table 4. Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million) – by Modality
Table 5. Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million) – by Viral
Table 6. Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million) – by Non-Viral
Table 7. Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million) – by Physical/mechanical Method
Table 8. Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million) – by Chemical Method
Table 9. Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million) – by Application
Table 10. Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million) – by End Users
Table 11. Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 12. United Kingdom: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 13. United Kingdom: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 14. United Kingdom: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 15. United Kingdom: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 16. United Kingdom: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 17. United Kingdom: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 18. United Kingdom: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 19. United Kingdom: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 20. Germany: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 21. Germany: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 22. Germany: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 23. Germany: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 24. Germany: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 25. Germany: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 26. Germany: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 27. Germany: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 28. France: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 29. France: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 30. France: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 31. France: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 32. France: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 33. France: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 34. France: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 35. France: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 36. Italy: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 37. Italy: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 38. Italy: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 39. Italy: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 40. Italy: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 41. Italy: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 42. Italy: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 43. Italy: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 44. Spain: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 45. Spain: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 46. Spain: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 47. Spain: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 48. Spain: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 49. Spain: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 50. Spain: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 51. Spain: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 52. Rest of Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 53. Rest of Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Modality
Table 54. Rest of Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Viral
Table 55. Rest of Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Non-Viral
Table 56. Rest of Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Physical/mechanical Method
Table 57. Rest of Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Chemical Method
Table 58. Rest of Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 59. Rest of Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million) – by End Users
Table 60. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
Table 61. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market

LIST OF FIGURES

Figure 1. Europe Transfection Reagents and Equipment Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Europe Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
Figure 4. Europe Transfection Reagents and Equipment Market Share (%) – by Product (2022 and 2030)
Figure 5. Reagents: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 6. Equipment: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Europe Transfection Reagents and Equipment Market Share (%) – by Modality (2022 and 2030)
Figure 8. Viral: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Retrovirus: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Adenovirus: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Adeno-Associated Virus: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Herpes Virus: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Non-Viral: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Physical/Mechanical: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Electroporation: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Microinjection: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Biolistic Method: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Laser Method: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Magnetofection: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Sonoporation: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Chemical Method: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Non-Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Hybrid: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Europe Transfection Reagents and Equipment Market Share (%) – by Application (2022 and 2030)
Figure 26. Biomedical Research: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Protein Production: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Therapeutic Delivery: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Europe Transfection Reagents and Equipment Market Share (%) – by End Users (2022 and 2030)
Figure 30. Academic and Research Institutes: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Pharmaceutical and Biotechnological Companies: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. Europe: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)
Figure 33. Europe: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 34. United Kingdom: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 35. Germany: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 36. France: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 37. Italy: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 38. Spain: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 39. Rest of Europe: Transfection Reagents and Equipment Market – Revenue and Forecast to 2030(US$ Million)
Figure 40. Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023

The List of Companies – Europe Transfection Reagents and Equipment Market

1. Thermo Fisher Scientific Inc
2. Promega Corp
3. F. Hoffmann-La Roche Ltd
4. Bio-Rad Laboratories Inc
5. Mirus Bio LLC
6. QIAGEN NV
7. Merck KGaA
8. Lonza Group AG
9. MaxCyte Inc
10. Polyplus-Transfection SA

Reviews

There are no reviews yet.

Be the first to review “Europe Transfection Reagents and Equipment Market Forecast to 2030”